Tag: risk

One class of drug used to treat type 2 diabetes may not reduce the risk of death when compared with placebo

One class of drug used to treat type 2 diabetes may not reduce the risk of death when compared with placebo, suggests new findings. The research, led by scientists from Imperial College London and published in the Journal of the American Medical Association, studied three types of diabetes treatment: sodium-glucose cotransporter 2 (SGLT-2) inhibitors, glucagon-like

Drowsy driving in the ridesharing industry is a public safety risk

A position statement from the American Academy of Sleep Medicine (AASM) concludes that fatigue and sleepiness are inherent safety risks in the ridesharing industry. Both sleep deprivation and circadian influences leave ridesharing drivers at risk for drowsy driving. The typical schedule for workers in the ridesharing industry may lead to driving after extended periods of

DPP-4I not tied to increased risk of acute pancreatitis in seniors

(HealthDay)—For older adults, dipeptidyl peptidase 4 inhibitors (DPP-4Is) are not associated with increased risk of acute pancreatitis, according to a study published online April 4 in Diabetes Care. Jin-Liern Hong, Ph.D., from the University of North Carolina at Chapel Hill, and colleagues examined the risks of acute pancreatitis among U.S. Medicare beneficiaries, aged 66+ years,

Those living near oil and gas facilities may be at higher risk of disease

People living near oil and gas facilities along Colorado’s Northern Front Range may be exposed to hazardous air pollutants, including carcinogens like benzene, that could pose health risks above levels deemed acceptable by the U.S. Environmental Protection Agency, according to researchers at the Colorado School of Public Health, Boulder County Public Health, CU Boulder, the

Montreal Parkinson risk of dementia scale deemed accurate

(HealthDay)—The office-based, eight-item Montreal Parkinson Risk of Dementia Scale is a valid predictor of development of dementia, according to a study published online March 26 in JAMA Neurology. Benjamin K. Dawson, from McGill University in Montreal, and colleagues conducted a multicenter study using four diverse Parkinson’s disease cohorts with a prospective 4.4-year follow-up to examine